This article is another one of multiple signs that Brilacidin will likely be successful (show efficacy) in its Phase 2 clinical trial.

Is Leo now:

--engaging in preliminary negotiations for partnering with pharmas
--engaging in preliminary negotiations for licensing agreements
--submitting manufacturing orders for future distribution of Brilacidin
--submitting further applications for Gov. grants
--readying an EUA application for Aug. insertion of trial results
--working on nasal nebulizer form of Brilacidin
--working on pill form of Brilacidin
???

Lots of strategic possibilities on the table, and only a matter of weeks to have some answers.